| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 277.89 | 2.7% | 19.4% |
| Total Income | 278.92 | 1.9% | 19.0% |
| Expenditure | 248.85 | 1.4% | 24.9% |
| PBT | 30.07 | 6.9% | 14.4% |
| Net Profit | 23.23 | 8.4% | 13.1% |
| OPM | 18.37% | 2.22pp | 1.55pp |
| NPM | 8.33% | 0.49pp | 3.07pp |
| EPS | 2.40 | 10.6% | 12.4% |
Detailed report is being prepared.
Momentum Test: Can Alcobev Surge Sustain Into H2?
Q1's 47% branded spirits jump signals pricing power in a bearish market. Q2 will test whether momentum holds as the stock sits 27% below its August peak—Street targets remain thin and wide.
What To Expect
Piccadily Agro's Q2 print will hinge on whether the branded spirits surge that delivered 47.3% YoY growth in Q1 (Alcobev jumped from ₹38.9 Cr to ₹57.2 Cr) carries through H2. On-plan trajectory would show double-digit revenue growth sustained (Q1 hit ₹270.5 Cr, +18.1% YoY), with the gross mix continuing to lift average realization—but watch the margin line: Q1 standalone PAT grew 15.4% YoY despite a sequential drop in profit, signaling either volume payoff or cost absorption pressure.
~₹280–295 Cr
implies 15–20% YoY growth; Q1 baseline ₹270.5 Cr; sequential range typical for spirits seasonality
sustain or ease?
Q1's 47% surge is the headline metric; Street watching for evidence of pricing power vs inventory pull
15–20% consolidated
PAT likely ₹21–24 Cr if on-plan; Q1 consolidated margin 7.9%; raw material costs and excise remain pressure points
₹590
below 50-day MA (₹591.94), bearish flag; but above 200-day (₹608.66) signals no freefall
Strong Q2 would show Alcobev continuing 30%+ YoY growth, revenue flat-to-up quarter-on-quarter (seasonal lift common in H2), margins steady or expanding on pricing. Weak Q2 would flag Alcobev moderation, inventory normalization post-Q1 surge, or margin compression from raw-material inflation—any sign of guidance miss would pressure a stock already 27% off its August peak.
On Track to Guidance?
No explicit full-year FY27 guidance has been disclosed in recent filings. Q1 trajectory (18.1% revenue growth, 16.3% PAT growth, strong Alcobev momentum) is ahead of FY26's full-year pace (when FY26 ended with slower Q4 growth). The company's 32nd annual report noted strategic focus on premium brands (Indri, Camikara) and distillery expansion. On-plan for Q2 would mean the spirits mix continues to offset slower movement in other segments, and the scheme of arrangement (cleared by BSE/NSE on Aug 17) poses no operational drag.
Street View
Since Last Quarter
1 · Premium brand momentum
Indri Diwali Collector's Edition (Oct 8) and Camikara international awards (Sep 3) signal brand investment. Indri's top-3 finish at IWC 2026 is the kind of press that supports pricing narrative.
2 · Scheme of arrangement cleared (Aug 17)
No adverse observations from BSE/NSE. Routine corporate restructuring; operational impact minimal—watch for clarification on any changes to reporting segments at Q2 call.
3 · Dividend paid (Sep 18 record date)
Final dividend of ₹1/share for FY26 paid; 32nd AGM held Sep 25. No surprises; auditor appointment (Rattan Kaur & Co.) noted at Q1 meeting.
4 · Insider activity
Q3 trading window closed (Sep 21) per routine SEBI protocol; no pledges or bulk deals reported. Promoter holding stable at 68.6%.
The Setup
Piccadily Agro delivered a confidence-building Q1, with spirits (Alcobev) surging 47% and revenue climbing 18%. The stock, however, remains 27% below its August peak, bearish technicals (below 50-day MA, volume ebbing), and thin analyst coverage mean the narrative is fragile. Q2 becomes a momentum test: if Alcobev sustains 30%+ growth and margins hold, the Street may re-rate on pricing power and brand strength; if Alcobev eases or margins compress, the chart likely breaks lower. Management commentary on full-year expectations, excise dynamics, and distribution (especially for premium lines) will be as important as the top-line number itself.
What to Watch on Result Day
1 · Alcobev segment—is 40%+ growth the new normal, or Q1 event?
The spirits business is Piccadily's call option. Moderation to 15–25% YoY would risk a 5–10% stock move down; acceleration to 45%+ would justify multiple expansion and possibly draw fresh analyst coverage.
2 · Consolidated margin trajectory
Watch EBITDA margin (Q1 ~11–12% est.) and PAT margin. Expansion signals operating leverage; compression signals input-cost inflation or mix headwinds.
3 · FY27 guidance and full-year outlook
Management commentary on revenue/profit run-rate and any risks (excise, commodity cost, demand). This stock has no codified guidance; narrative guidance will frame the next 2–3 quarters of Street view.
4 · Scheme of arrangement impact
Confirm no operational disruption or segment realignment that would affect forward comparability. Clarify any reporting changes for Q3/Q4.
Piccadily Agro's Q2 print is a fork: premium brands (Indri, Camikara) and spirits momentum hold, the stock could re-rate back toward ₹700+ on confidence in sustainable 18%+ revenue and 15%+ PAT growth; if momentum eases or guidance is silent, the technical break-down from ₹590 to support (~₹570) is plausible, and coverage will remain thin. The Street needs conviction from management on H2 outlook.